nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—EBP—Tamoxifen—pancreatic cancer	0.558	0.699	CbGbCtD
Pentazocine—SIGMAR1—Tamoxifen—pancreatic cancer	0.24	0.3	CbGbCtD
Pentazocine—EBP—Azacitidine—Gemcitabine—pancreatic cancer	0.00244	1	CbGdCrCtD
Pentazocine—Visual disturbance—Docetaxel—pancreatic cancer	0.000556	0.00516	CcSEcCtD
Pentazocine—Sweating—Gemcitabine—pancreatic cancer	0.000549	0.0051	CcSEcCtD
Pentazocine—Dysgeusia—Sunitinib—pancreatic cancer	0.000546	0.00507	CcSEcCtD
Pentazocine—Dry mouth—Tamoxifen—pancreatic cancer	0.000542	0.00503	CcSEcCtD
Pentazocine—Muscle spasms—Sunitinib—pancreatic cancer	0.000536	0.00498	CcSEcCtD
Pentazocine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000534	0.00496	CcSEcCtD
Pentazocine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000525	0.00488	CcSEcCtD
Pentazocine—Ulcer—Epirubicin—pancreatic cancer	0.000518	0.00481	CcSEcCtD
Pentazocine—Shock—Erlotinib—pancreatic cancer	0.000517	0.0048	CcSEcCtD
Pentazocine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000513	0.00477	CcSEcCtD
Pentazocine—Visual impairment—Irinotecan—pancreatic cancer	0.000508	0.00472	CcSEcCtD
Pentazocine—Anorexia—Tamoxifen—pancreatic cancer	0.000506	0.0047	CcSEcCtD
Pentazocine—Anorexia—Erlotinib—pancreatic cancer	0.000501	0.00465	CcSEcCtD
Pentazocine—Flushing—Irinotecan—pancreatic cancer	0.000489	0.00455	CcSEcCtD
Pentazocine—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000486	0.00451	CcSEcCtD
Pentazocine—Hypertension—Sunitinib—pancreatic cancer	0.000481	0.00447	CcSEcCtD
Pentazocine—Insomnia—Tamoxifen—pancreatic cancer	0.00048	0.00446	CcSEcCtD
Pentazocine—Ulcer—Doxorubicin—pancreatic cancer	0.000479	0.00445	CcSEcCtD
Pentazocine—Paraesthesia—Tamoxifen—pancreatic cancer	0.000477	0.00443	CcSEcCtD
Pentazocine—Insomnia—Erlotinib—pancreatic cancer	0.000475	0.00441	CcSEcCtD
Pentazocine—Cramp muscle—Docetaxel—pancreatic cancer	0.000474	0.00441	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000474	0.00441	CcSEcCtD
Pentazocine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000473	0.0044	CcSEcCtD
Pentazocine—Chills—Irinotecan—pancreatic cancer	0.000473	0.00439	CcSEcCtD
Pentazocine—Dyspnoea—Erlotinib—pancreatic cancer	0.000468	0.00435	CcSEcCtD
Pentazocine—Dry mouth—Sunitinib—pancreatic cancer	0.000464	0.00431	CcSEcCtD
Pentazocine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000462	0.00429	CcSEcCtD
Pentazocine—Chills—Gemcitabine—pancreatic cancer	0.000461	0.00428	CcSEcCtD
Pentazocine—Decreased appetite—Erlotinib—pancreatic cancer	0.000457	0.00424	CcSEcCtD
Pentazocine—Constipation—Tamoxifen—pancreatic cancer	0.000454	0.00422	CcSEcCtD
Pentazocine—Constipation—Erlotinib—pancreatic cancer	0.000449	0.00417	CcSEcCtD
Pentazocine—Shock—Sunitinib—pancreatic cancer	0.000447	0.00416	CcSEcCtD
Pentazocine—Muscle spasms—Irinotecan—pancreatic cancer	0.000441	0.0041	CcSEcCtD
Pentazocine—Anorexia—Sunitinib—pancreatic cancer	0.000434	0.00403	CcSEcCtD
Pentazocine—Vision blurred—Fluorouracil—pancreatic cancer	0.000414	0.00385	CcSEcCtD
Pentazocine—Vertigo—Irinotecan—pancreatic cancer	0.000412	0.00383	CcSEcCtD
Pentazocine—Syncope—Irinotecan—pancreatic cancer	0.000412	0.00382	CcSEcCtD
Pentazocine—Insomnia—Sunitinib—pancreatic cancer	0.000411	0.00382	CcSEcCtD
Pentazocine—Paraesthesia—Sunitinib—pancreatic cancer	0.000408	0.00379	CcSEcCtD
Pentazocine—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000407	0.00378	CcSEcCtD
Pentazocine—Dyspnoea—Sunitinib—pancreatic cancer	0.000405	0.00377	CcSEcCtD
Pentazocine—Loss of consciousness—Irinotecan—pancreatic cancer	0.000403	0.00375	CcSEcCtD
Pentazocine—Hypertension—Irinotecan—pancreatic cancer	0.000396	0.00368	CcSEcCtD
Pentazocine—Decreased appetite—Sunitinib—pancreatic cancer	0.000395	0.00367	CcSEcCtD
Pentazocine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000391	0.00363	CcSEcCtD
Pentazocine—Constipation—Sunitinib—pancreatic cancer	0.000389	0.00361	CcSEcCtD
Pentazocine—Hypertension—Gemcitabine—pancreatic cancer	0.000386	0.00359	CcSEcCtD
Pentazocine—Asthenia—Tamoxifen—pancreatic cancer	0.000381	0.00354	CcSEcCtD
Pentazocine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000379	0.00352	CcSEcCtD
Pentazocine—Confusional state—Irinotecan—pancreatic cancer	0.000378	0.00351	CcSEcCtD
Pentazocine—Asthenia—Erlotinib—pancreatic cancer	0.000377	0.0035	CcSEcCtD
Pentazocine—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000376	0.0035	CcSEcCtD
Pentazocine—Pruritus—Tamoxifen—pancreatic cancer	0.000376	0.00349	CcSEcCtD
Pentazocine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000375	0.00348	CcSEcCtD
Pentazocine—Pruritus—Erlotinib—pancreatic cancer	0.000372	0.00345	CcSEcCtD
Pentazocine—Shock—Irinotecan—pancreatic cancer	0.000369	0.00342	CcSEcCtD
Pentazocine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000365	0.00339	CcSEcCtD
Pentazocine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000363	0.00337	CcSEcCtD
Pentazocine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000362	0.00336	CcSEcCtD
Pentazocine—Confusional state—Fluorouracil—pancreatic cancer	0.000362	0.00336	CcSEcCtD
Pentazocine—Diarrhoea—Erlotinib—pancreatic cancer	0.000359	0.00334	CcSEcCtD
Pentazocine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000359	0.00333	CcSEcCtD
Pentazocine—Anorexia—Irinotecan—pancreatic cancer	0.000357	0.00332	CcSEcCtD
Pentazocine—Diplopia—Epirubicin—pancreatic cancer	0.000355	0.0033	CcSEcCtD
Pentazocine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000353	0.00328	CcSEcCtD
Pentazocine—Visual impairment—Docetaxel—pancreatic cancer	0.000351	0.00326	CcSEcCtD
Pentazocine—Dizziness—Tamoxifen—pancreatic cancer	0.000351	0.00326	CcSEcCtD
Pentazocine—Tachycardia—Fluorouracil—pancreatic cancer	0.00035	0.00325	CcSEcCtD
Pentazocine—Hypotension—Irinotecan—pancreatic cancer	0.00035	0.00325	CcSEcCtD
Pentazocine—Anorexia—Gemcitabine—pancreatic cancer	0.000348	0.00323	CcSEcCtD
Pentazocine—Dizziness—Erlotinib—pancreatic cancer	0.000347	0.00323	CcSEcCtD
Pentazocine—Erythema multiforme—Docetaxel—pancreatic cancer	0.000345	0.0032	CcSEcCtD
Pentazocine—Face oedema—Epirubicin—pancreatic cancer	0.000343	0.00319	CcSEcCtD
Pentazocine—Anorexia—Fluorouracil—pancreatic cancer	0.000342	0.00318	CcSEcCtD
Pentazocine—Hypotension—Gemcitabine—pancreatic cancer	0.000341	0.00317	CcSEcCtD
Pentazocine—Insomnia—Irinotecan—pancreatic cancer	0.000339	0.00315	CcSEcCtD
Pentazocine—Flushing—Docetaxel—pancreatic cancer	0.000338	0.00314	CcSEcCtD
Pentazocine—Vomiting—Tamoxifen—pancreatic cancer	0.000338	0.00314	CcSEcCtD
Pentazocine—Paraesthesia—Irinotecan—pancreatic cancer	0.000336	0.00312	CcSEcCtD
Pentazocine—Hypotension—Fluorouracil—pancreatic cancer	0.000335	0.00311	CcSEcCtD
Pentazocine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000335	0.00311	CcSEcCtD
Pentazocine—Dermatitis—Tamoxifen—pancreatic cancer	0.000335	0.00311	CcSEcCtD
Pentazocine—Vomiting—Erlotinib—pancreatic cancer	0.000334	0.0031	CcSEcCtD
Pentazocine—Dyspnoea—Irinotecan—pancreatic cancer	0.000334	0.0031	CcSEcCtD
Pentazocine—Somnolence—Irinotecan—pancreatic cancer	0.000333	0.00309	CcSEcCtD
Pentazocine—Headache—Tamoxifen—pancreatic cancer	0.000333	0.00309	CcSEcCtD
Pentazocine—Dermatitis—Erlotinib—pancreatic cancer	0.000331	0.00307	CcSEcCtD
Pentazocine—Insomnia—Gemcitabine—pancreatic cancer	0.00033	0.00307	CcSEcCtD
Pentazocine—Headache—Erlotinib—pancreatic cancer	0.000329	0.00306	CcSEcCtD
Pentazocine—Diplopia—Doxorubicin—pancreatic cancer	0.000329	0.00305	CcSEcCtD
Pentazocine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000328	0.00304	CcSEcCtD
Pentazocine—Chills—Docetaxel—pancreatic cancer	0.000327	0.00304	CcSEcCtD
Pentazocine—Asthenia—Sunitinib—pancreatic cancer	0.000326	0.00303	CcSEcCtD
Pentazocine—Decreased appetite—Irinotecan—pancreatic cancer	0.000326	0.00303	CcSEcCtD
Pentazocine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000325	0.00302	CcSEcCtD
Pentazocine—Insomnia—Fluorouracil—pancreatic cancer	0.000325	0.00301	CcSEcCtD
Pentazocine—Somnolence—Gemcitabine—pancreatic cancer	0.000324	0.00301	CcSEcCtD
Pentazocine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000322	0.00299	CcSEcCtD
Pentazocine—Pruritus—Sunitinib—pancreatic cancer	0.000322	0.00299	CcSEcCtD
Pentazocine—Constipation—Irinotecan—pancreatic cancer	0.00032	0.00298	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00032	0.00297	CcSEcCtD
Pentazocine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00032	0.00297	CcSEcCtD
Pentazocine—Somnolence—Fluorouracil—pancreatic cancer	0.000319	0.00296	CcSEcCtD
Pentazocine—Face oedema—Doxorubicin—pancreatic cancer	0.000317	0.00295	CcSEcCtD
Pentazocine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000317	0.00295	CcSEcCtD
Pentazocine—Nausea—Tamoxifen—pancreatic cancer	0.000315	0.00293	CcSEcCtD
Pentazocine—Constipation—Gemcitabine—pancreatic cancer	0.000312	0.0029	CcSEcCtD
Pentazocine—Nausea—Erlotinib—pancreatic cancer	0.000312	0.0029	CcSEcCtD
Pentazocine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000312	0.0029	CcSEcCtD
Pentazocine—Diarrhoea—Sunitinib—pancreatic cancer	0.000311	0.00289	CcSEcCtD
Pentazocine—Dysgeusia—Docetaxel—pancreatic cancer	0.000311	0.00289	CcSEcCtD
Pentazocine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000309	0.00287	CcSEcCtD
Pentazocine—Muscle spasms—Docetaxel—pancreatic cancer	0.000305	0.00283	CcSEcCtD
Pentazocine—Eosinophilia—Epirubicin—pancreatic cancer	0.000304	0.00283	CcSEcCtD
Pentazocine—Dizziness—Sunitinib—pancreatic cancer	0.000301	0.00279	CcSEcCtD
Pentazocine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000301	0.00279	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000296	0.00275	CcSEcCtD
Pentazocine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000296	0.00275	CcSEcCtD
Pentazocine—Vomiting—Sunitinib—pancreatic cancer	0.000289	0.00269	CcSEcCtD
Pentazocine—Dermatitis—Sunitinib—pancreatic cancer	0.000286	0.00266	CcSEcCtD
Pentazocine—Headache—Sunitinib—pancreatic cancer	0.000285	0.00265	CcSEcCtD
Pentazocine—Syncope—Docetaxel—pancreatic cancer	0.000285	0.00264	CcSEcCtD
Pentazocine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000281	0.00261	CcSEcCtD
Pentazocine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000279	0.00259	CcSEcCtD
Pentazocine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000276	0.00256	CcSEcCtD
Pentazocine—Hypertension—Docetaxel—pancreatic cancer	0.000274	0.00254	CcSEcCtD
Pentazocine—Nausea—Sunitinib—pancreatic cancer	0.00027	0.00251	CcSEcCtD
Pentazocine—Asthenia—Irinotecan—pancreatic cancer	0.000269	0.0025	CcSEcCtD
Pentazocine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000264	0.00246	CcSEcCtD
Pentazocine—Dry mouth—Docetaxel—pancreatic cancer	0.000264	0.00245	CcSEcCtD
Pentazocine—Sweating—Epirubicin—pancreatic cancer	0.000263	0.00244	CcSEcCtD
Pentazocine—Asthenia—Gemcitabine—pancreatic cancer	0.000262	0.00243	CcSEcCtD
Pentazocine—Confusional state—Docetaxel—pancreatic cancer	0.000261	0.00243	CcSEcCtD
Pentazocine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000259	0.00241	CcSEcCtD
Pentazocine—Pruritus—Gemcitabine—pancreatic cancer	0.000258	0.0024	CcSEcCtD
Pentazocine—Diarrhoea—Irinotecan—pancreatic cancer	0.000256	0.00238	CcSEcCtD
Pentazocine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000256	0.00237	CcSEcCtD
Pentazocine—Shock—Docetaxel—pancreatic cancer	0.000255	0.00237	CcSEcCtD
Pentazocine—Pruritus—Fluorouracil—pancreatic cancer	0.000254	0.00236	CcSEcCtD
Pentazocine—Tachycardia—Docetaxel—pancreatic cancer	0.000253	0.00235	CcSEcCtD
Pentazocine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00025	0.00232	CcSEcCtD
Pentazocine—Dizziness—Irinotecan—pancreatic cancer	0.000248	0.0023	CcSEcCtD
Pentazocine—Anorexia—Docetaxel—pancreatic cancer	0.000247	0.00229	CcSEcCtD
Pentazocine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000246	0.00228	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—pancreatic cancer	0.000243	0.00226	CcSEcCtD
Pentazocine—Hypotension—Docetaxel—pancreatic cancer	0.000242	0.00225	CcSEcCtD
Pentazocine—Vomiting—Irinotecan—pancreatic cancer	0.000238	0.00221	CcSEcCtD
Pentazocine—Dizziness—Fluorouracil—pancreatic cancer	0.000237	0.0022	CcSEcCtD
Pentazocine—Visual impairment—Epirubicin—pancreatic cancer	0.000237	0.0022	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000236	0.0022	CcSEcCtD
Pentazocine—Dermatitis—Irinotecan—pancreatic cancer	0.000236	0.00219	CcSEcCtD
Pentazocine—Headache—Irinotecan—pancreatic cancer	0.000235	0.00218	CcSEcCtD
Pentazocine—Insomnia—Docetaxel—pancreatic cancer	0.000234	0.00218	CcSEcCtD
Pentazocine—Paraesthesia—Docetaxel—pancreatic cancer	0.000233	0.00216	CcSEcCtD
Pentazocine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000232	0.00216	CcSEcCtD
Pentazocine—Vomiting—Gemcitabine—pancreatic cancer	0.000232	0.00216	CcSEcCtD
Pentazocine—Dyspnoea—Docetaxel—pancreatic cancer	0.000231	0.00214	CcSEcCtD
Pentazocine—Somnolence—Docetaxel—pancreatic cancer	0.00023	0.00214	CcSEcCtD
Pentazocine—Dermatitis—Gemcitabine—pancreatic cancer	0.00023	0.00214	CcSEcCtD
Pentazocine—Tinnitus—Epirubicin—pancreatic cancer	0.000229	0.00213	CcSEcCtD
Pentazocine—Headache—Gemcitabine—pancreatic cancer	0.000229	0.00212	CcSEcCtD
Pentazocine—Flushing—Epirubicin—pancreatic cancer	0.000228	0.00212	CcSEcCtD
Pentazocine—Vomiting—Fluorouracil—pancreatic cancer	0.000228	0.00212	CcSEcCtD
Pentazocine—Dermatitis—Fluorouracil—pancreatic cancer	0.000226	0.0021	CcSEcCtD
Pentazocine—Decreased appetite—Docetaxel—pancreatic cancer	0.000225	0.00209	CcSEcCtD
Pentazocine—Headache—Fluorouracil—pancreatic cancer	0.000225	0.00209	CcSEcCtD
Pentazocine—Nausea—Irinotecan—pancreatic cancer	0.000223	0.00207	CcSEcCtD
Pentazocine—Constipation—Docetaxel—pancreatic cancer	0.000221	0.00206	CcSEcCtD
Pentazocine—Chills—Epirubicin—pancreatic cancer	0.000221	0.00205	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—pancreatic cancer	0.000219	0.00204	CcSEcCtD
Pentazocine—Nausea—Gemcitabine—pancreatic cancer	0.000217	0.00201	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000215	0.002	CcSEcCtD
Pentazocine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000213	0.00198	CcSEcCtD
Pentazocine—Nausea—Fluorouracil—pancreatic cancer	0.000213	0.00198	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—pancreatic cancer	0.000212	0.00197	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—pancreatic cancer	0.000211	0.00196	CcSEcCtD
Pentazocine—Dysgeusia—Epirubicin—pancreatic cancer	0.00021	0.00195	CcSEcCtD
Pentazocine—Muscle spasms—Epirubicin—pancreatic cancer	0.000206	0.00191	CcSEcCtD
Pentazocine—Chills—Doxorubicin—pancreatic cancer	0.000204	0.0019	CcSEcCtD
Pentazocine—Vision blurred—Epirubicin—pancreatic cancer	0.000202	0.00187	CcSEcCtD
Pentazocine—Agitation—Epirubicin—pancreatic cancer	0.000197	0.00183	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000194	0.0018	CcSEcCtD
Pentazocine—Vertigo—Epirubicin—pancreatic cancer	0.000192	0.00179	CcSEcCtD
Pentazocine—Syncope—Epirubicin—pancreatic cancer	0.000192	0.00178	CcSEcCtD
Pentazocine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000191	0.00177	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—pancreatic cancer	0.00019	0.00177	CcSEcCtD
Pentazocine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000188	0.00175	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—pancreatic cancer	0.000187	0.00173	CcSEcCtD
Pentazocine—Asthenia—Docetaxel—pancreatic cancer	0.000186	0.00173	CcSEcCtD
Pentazocine—Hypertension—Epirubicin—pancreatic cancer	0.000185	0.00172	CcSEcCtD
Pentazocine—Pruritus—Docetaxel—pancreatic cancer	0.000183	0.0017	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—pancreatic cancer	0.000182	0.00169	CcSEcCtD
Pentazocine—Dry mouth—Epirubicin—pancreatic cancer	0.000178	0.00166	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—pancreatic cancer	0.000178	0.00165	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—pancreatic cancer	0.000178	0.00165	CcSEcCtD
Pentazocine—Diarrhoea—Docetaxel—pancreatic cancer	0.000177	0.00165	CcSEcCtD
Pentazocine—Confusional state—Epirubicin—pancreatic cancer	0.000176	0.00164	CcSEcCtD
Pentazocine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000175	0.00162	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000174	0.00162	CcSEcCtD
Pentazocine—Shock—Epirubicin—pancreatic cancer	0.000172	0.0016	CcSEcCtD
Pentazocine—Dizziness—Docetaxel—pancreatic cancer	0.000171	0.00159	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—pancreatic cancer	0.000171	0.00159	CcSEcCtD
Pentazocine—Tachycardia—Epirubicin—pancreatic cancer	0.00017	0.00158	CcSEcCtD
Pentazocine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000169	0.00157	CcSEcCtD
Pentazocine—Anorexia—Epirubicin—pancreatic cancer	0.000167	0.00155	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—pancreatic cancer	0.000165	0.00153	CcSEcCtD
Pentazocine—Vomiting—Docetaxel—pancreatic cancer	0.000165	0.00153	CcSEcCtD
Pentazocine—Hypotension—Epirubicin—pancreatic cancer	0.000163	0.00152	CcSEcCtD
Pentazocine—Dermatitis—Docetaxel—pancreatic cancer	0.000163	0.00152	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—pancreatic cancer	0.000163	0.00151	CcSEcCtD
Pentazocine—Headache—Docetaxel—pancreatic cancer	0.000162	0.00151	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000162	0.0015	CcSEcCtD
Pentazocine—Shock—Doxorubicin—pancreatic cancer	0.000159	0.00148	CcSEcCtD
Pentazocine—Insomnia—Epirubicin—pancreatic cancer	0.000158	0.00147	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—pancreatic cancer	0.000158	0.00147	CcSEcCtD
Pentazocine—Paraesthesia—Epirubicin—pancreatic cancer	0.000157	0.00146	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000156	0.00145	CcSEcCtD
Pentazocine—Dyspnoea—Epirubicin—pancreatic cancer	0.000156	0.00145	CcSEcCtD
Pentazocine—Somnolence—Epirubicin—pancreatic cancer	0.000155	0.00144	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—pancreatic cancer	0.000154	0.00143	CcSEcCtD
Pentazocine—Nausea—Docetaxel—pancreatic cancer	0.000154	0.00143	CcSEcCtD
Pentazocine—Decreased appetite—Epirubicin—pancreatic cancer	0.000152	0.00141	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—pancreatic cancer	0.000151	0.0014	CcSEcCtD
Pentazocine—Constipation—Epirubicin—pancreatic cancer	0.000149	0.00139	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—pancreatic cancer	0.000146	0.00136	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000145	0.00135	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000144	0.00134	CcSEcCtD
Pentazocine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000144	0.00134	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—pancreatic cancer	0.000144	0.00133	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000141	0.00131	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—pancreatic cancer	0.000138	0.00128	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000133	0.00124	CcSEcCtD
Pentazocine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000129	0.0012	CcSEcCtD
Pentazocine—Asthenia—Epirubicin—pancreatic cancer	0.000125	0.00116	CcSEcCtD
Pentazocine—Pruritus—Epirubicin—pancreatic cancer	0.000124	0.00115	CcSEcCtD
Pentazocine—Diarrhoea—Epirubicin—pancreatic cancer	0.00012	0.00111	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000119	0.00111	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—pancreatic cancer	0.000116	0.00108	CcSEcCtD
Pentazocine—Dizziness—Epirubicin—pancreatic cancer	0.000116	0.00107	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—pancreatic cancer	0.000114	0.00106	CcSEcCtD
Pentazocine—Vomiting—Epirubicin—pancreatic cancer	0.000111	0.00103	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000111	0.00103	CcSEcCtD
Pentazocine—Dermatitis—Epirubicin—pancreatic cancer	0.00011	0.00102	CcSEcCtD
Pentazocine—Headache—Epirubicin—pancreatic cancer	0.000109	0.00102	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—pancreatic cancer	0.000107	0.000993	CcSEcCtD
Pentazocine—Nausea—Epirubicin—pancreatic cancer	0.000104	0.000964	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—pancreatic cancer	0.000103	0.000955	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—pancreatic cancer	0.000102	0.000946	CcSEcCtD
Pentazocine—Headache—Doxorubicin—pancreatic cancer	0.000101	0.000941	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—pancreatic cancer	9.6e-05	0.000892	CcSEcCtD
Pentazocine—OPRK1—Signaling by GPCR—SST—pancreatic cancer	6.89e-05	0.000744	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	6.87e-05	0.000742	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GAST—pancreatic cancer	6.77e-05	0.000732	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GCG—pancreatic cancer	6.76e-05	0.000731	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—SHH—pancreatic cancer	6.71e-05	0.000726	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AGTR1—pancreatic cancer	6.68e-05	0.000722	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IAPP—pancreatic cancer	6.63e-05	0.000717	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CD—pancreatic cancer	6.61e-05	0.000715	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SSTR3—pancreatic cancer	6.55e-05	0.000708	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—DTX1—pancreatic cancer	6.55e-05	0.000708	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—DTX4—pancreatic cancer	6.49e-05	0.000702	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GLI1—pancreatic cancer	6.49e-05	0.000702	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AGTR1—pancreatic cancer	6.45e-05	0.000697	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SCT—pancreatic cancer	6.42e-05	0.000694	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HEY1—pancreatic cancer	6.42e-05	0.000694	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—SST—pancreatic cancer	6.41e-05	0.000693	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PTHLH—pancreatic cancer	6.37e-05	0.000688	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PTCH1—pancreatic cancer	6.37e-05	0.000688	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CNR1—pancreatic cancer	6.36e-05	0.000687	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PPP2R5B—pancreatic cancer	6.31e-05	0.000682	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NRP1—pancreatic cancer	6.31e-05	0.000682	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SSTR1—pancreatic cancer	6.28e-05	0.000678	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PPY—pancreatic cancer	6.16e-05	0.000665	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GCG—pancreatic cancer	6.14e-05	0.000664	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCK—pancreatic cancer	6.12e-05	0.000662	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HEY2—pancreatic cancer	6.08e-05	0.000657	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SSTR2—pancreatic cancer	6.04e-05	0.000653	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CNR2—pancreatic cancer	5.97e-05	0.000645	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GLP1R—pancreatic cancer	5.97e-05	0.000645	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL8—pancreatic cancer	5.96e-05	0.000645	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GAST—pancreatic cancer	5.94e-05	0.000642	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CNR1—pancreatic cancer	5.92e-05	0.000639	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCKAR—pancreatic cancer	5.87e-05	0.000634	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AGTR1—pancreatic cancer	5.86e-05	0.000633	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCKBR—pancreatic cancer	5.84e-05	0.000631	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—SST—pancreatic cancer	5.82e-05	0.000629	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	5.8e-05	0.000627	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CB—pancreatic cancer	5.76e-05	0.000623	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GCG—pancreatic cancer	5.71e-05	0.000618	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PTGS2—pancreatic cancer	5.71e-05	0.000617	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JAG2—pancreatic cancer	5.69e-05	0.000615	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HEY1—pancreatic cancer	5.63e-05	0.000608	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SCT—pancreatic cancer	5.63e-05	0.000608	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MEN1—pancreatic cancer	5.61e-05	0.000606	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—DTX4—pancreatic cancer	5.49e-05	0.000593	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GLI1—pancreatic cancer	5.49e-05	0.000593	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGTR1—pancreatic cancer	5.45e-05	0.000589	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CNR1—pancreatic cancer	5.37e-05	0.000581	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCK—pancreatic cancer	5.37e-05	0.00058	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SHH—pancreatic cancer	5.35e-05	0.000578	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NRP1—pancreatic cancer	5.34e-05	0.000577	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	5.34e-05	0.000577	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH4—pancreatic cancer	5.32e-05	0.000575	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IAPP—pancreatic cancer	5.29e-05	0.000571	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CNR2—pancreatic cancer	5.23e-05	0.000566	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GLP1R—pancreatic cancer	5.23e-05	0.000566	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL8—pancreatic cancer	5.23e-05	0.000565	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GCG—pancreatic cancer	5.19e-05	0.000561	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCKAR—pancreatic cancer	5.15e-05	0.000556	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HEY2—pancreatic cancer	5.14e-05	0.000555	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTHLH—pancreatic cancer	5.07e-05	0.000548	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTCH1—pancreatic cancer	5.07e-05	0.000548	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GAST—pancreatic cancer	5.02e-05	0.000542	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JAG2—pancreatic cancer	4.99e-05	0.000539	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PTEN—pancreatic cancer	4.98e-05	0.000538	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGTR1—pancreatic cancer	4.95e-05	0.000535	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MEN1—pancreatic cancer	4.92e-05	0.000532	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SCT—pancreatic cancer	4.76e-05	0.000514	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HEY1—pancreatic cancer	4.76e-05	0.000514	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SHH—pancreatic cancer	4.69e-05	0.000507	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH4—pancreatic cancer	4.66e-05	0.000504	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SST—pancreatic cancer	4.64e-05	0.000502	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IAPP—pancreatic cancer	4.63e-05	0.000501	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.58e-05	0.000495	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JAG1—pancreatic cancer	4.54e-05	0.000491	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCK—pancreatic cancer	4.54e-05	0.00049	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH3—pancreatic cancer	4.52e-05	0.000489	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTHLH—pancreatic cancer	4.45e-05	0.000481	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTCH1—pancreatic cancer	4.45e-05	0.000481	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CNR2—pancreatic cancer	4.42e-05	0.000478	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GLP1R—pancreatic cancer	4.42e-05	0.000478	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	4.42e-05	0.000478	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	4.35e-05	0.00047	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	4.28e-05	0.000463	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	4.22e-05	0.000456	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	4.16e-05	0.000449	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	4.16e-05	0.000449	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GCG—pancreatic cancer	4.14e-05	0.000447	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SST—pancreatic cancer	4.07e-05	0.00044	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.02e-05	0.000435	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.01e-05	0.000434	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	3.98e-05	0.00043	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SHH—pancreatic cancer	3.97e-05	0.000429	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	3.97e-05	0.000429	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	3.95e-05	0.000426	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	3.94e-05	0.000426	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	3.92e-05	0.000423	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STK11—pancreatic cancer	3.89e-05	0.00042	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	3.76e-05	0.000406	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	3.76e-05	0.000406	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	3.76e-05	0.000406	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.65e-05	0.000395	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.64e-05	0.000394	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GCG—pancreatic cancer	3.63e-05	0.000392	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.53e-05	0.000381	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CA—pancreatic cancer	3.51e-05	0.00038	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.51e-05	0.000379	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	3.46e-05	0.000374	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SST—pancreatic cancer	3.44e-05	0.000372	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STK11—pancreatic cancer	3.41e-05	0.000369	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	3.41e-05	0.000368	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.39e-05	0.000367	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	3.37e-05	0.000364	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	3.37e-05	0.000364	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	3.35e-05	0.000362	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HES1—pancreatic cancer	3.33e-05	0.000359	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.2e-05	0.000346	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	3.18e-05	0.000344	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	3.17e-05	0.000343	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.08e-05	0.000333	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.08e-05	0.000332	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GCG—pancreatic cancer	3.07e-05	0.000331	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	3.06e-05	0.000331	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	2.99e-05	0.000323	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.98e-05	0.000322	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.96e-05	0.000319	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	2.92e-05	0.000316	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HES1—pancreatic cancer	2.92e-05	0.000315	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TERT—pancreatic cancer	2.91e-05	0.000315	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STK11—pancreatic cancer	2.88e-05	0.000311	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—pancreatic cancer	2.87e-05	0.00031	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.79e-05	0.000302	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	2.79e-05	0.000301	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	2.78e-05	0.0003	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOE—pancreatic cancer	2.72e-05	0.000294	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.71e-05	0.000293	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	2.68e-05	0.00029	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KDR—pancreatic cancer	2.67e-05	0.000288	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.6e-05	0.000281	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TERT—pancreatic cancer	2.56e-05	0.000276	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	2.54e-05	0.000274	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	2.52e-05	0.000273	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	2.51e-05	0.000271	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.5e-05	0.00027	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HES1—pancreatic cancer	2.46e-05	0.000266	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	2.46e-05	0.000265	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	2.46e-05	0.000265	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	2.44e-05	0.000264	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	2.44e-05	0.000263	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGF—pancreatic cancer	2.43e-05	0.000262	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOE—pancreatic cancer	2.39e-05	0.000258	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.36e-05	0.000255	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KDR—pancreatic cancer	2.34e-05	0.000253	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	2.27e-05	0.000245	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	2.24e-05	0.000242	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	2.22e-05	0.00024	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	2.2e-05	0.000238	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TERT—pancreatic cancer	2.16e-05	0.000233	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	2.16e-05	0.000233	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	2.15e-05	0.000233	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	2.15e-05	0.000233	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.14e-05	0.000231	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGF—pancreatic cancer	2.13e-05	0.00023	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	2.11e-05	0.000228	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	2.07e-05	0.000223	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	2.06e-05	0.000223	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOE—pancreatic cancer	2.02e-05	0.000218	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KDR—pancreatic cancer	1.98e-05	0.000213	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	1.96e-05	0.000212	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.94e-05	0.00021	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	1.89e-05	0.000205	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	1.88e-05	0.000203	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.88e-05	0.000203	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.87e-05	0.000203	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.86e-05	0.000201	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	1.85e-05	0.0002	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.82e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.82e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	1.81e-05	0.000195	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGF—pancreatic cancer	1.8e-05	0.000194	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	1.8e-05	0.000194	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	1.75e-05	0.000189	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	1.73e-05	0.000187	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.7e-05	0.000184	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	1.68e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.67e-05	0.00018	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.66e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	1.65e-05	0.000178	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	1.64e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	1.63e-05	0.000176	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.6e-05	0.000173	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.59e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	1.59e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.58e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	1.57e-05	0.00017	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.57e-05	0.000169	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	1.53e-05	0.000166	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	1.52e-05	0.000164	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SRC—pancreatic cancer	1.51e-05	0.000163	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	1.48e-05	0.00016	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.47e-05	0.000159	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	1.46e-05	0.000158	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	1.45e-05	0.000157	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	1.45e-05	0.000157	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.44e-05	0.000156	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	1.43e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	1.43e-05	0.000154	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.39e-05	0.000151	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	1.39e-05	0.00015	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—pancreatic cancer	1.35e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.35e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.34e-05	0.000145	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.33e-05	0.000144	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SRC—pancreatic cancer	1.32e-05	0.000143	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	1.32e-05	0.000143	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.29e-05	0.00014	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	1.29e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	1.28e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	1.27e-05	0.000138	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	1.27e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	1.25e-05	0.000135	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	1.25e-05	0.000135	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.24e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	1.21e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	1.2e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—pancreatic cancer	1.18e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	1.18e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.18e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	1.16e-05	0.000125	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	1.15e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SRC—pancreatic cancer	1.12e-05	0.000121	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TP53—pancreatic cancer	1.11e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	1.09e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.09e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	1.08e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	1.07e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	1.06e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	1.01e-05	0.000109	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—pancreatic cancer	1e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	9.99e-06	0.000108	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	9.79e-06	0.000106	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TP53—pancreatic cancer	9.73e-06	0.000105	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	9.37e-06	0.000101	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	9.3e-06	0.000101	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	9.25e-06	0.0001	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	8.5e-06	9.19e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TP53—pancreatic cancer	8.22e-06	8.89e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	8.22e-06	8.88e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	7.86e-06	8.5e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	6.94e-06	7.5e-05	CbGpPWpGaD
